ANDA 74833, held by Strides Pharma Intl. Acyclovir.
As of Nov 13, 2026, ANDA 74833 (Acyclovir), held by Strides Pharma Intl, was first approved by FDA on Apr 22, 1997, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 22, 1997 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acyclovir200MG ยท capsule;oral | Acyclovir | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 26, 1998 | Supplement 1Labeling | Approved | None posted |
| Apr 22, 1997 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
